MANCHESTER, United Kingdom--(BUSINESS WIRE)--Cytox Ltd, (Cytox) a leading developer of assays for risk assessment and prediction of dementia, announced the start of two landmark exploratory clinical trials designed to evaluate a new blood assay platform that could potentially assist in the evaluation of an individual’s risk for dementia and Alzheimer’s.
Help employers find you! Check out all the jobs and post your resume.
